Q&A with Jeppe Høier, partner, Maersk Growth
Month: June 2021
Vertical Aerospace agrees to go public
The equity market for UK-based private companies is taking off and while the golden triangle between London, Oxford and Cambridge is often seen as the heart of the country’s innovation and deeptech creativity, there are some exciting initiatives happening further west.
Waymo drives through to $2.5bn round
Alphabet, AutoNation and Magna International all returned to reinvest in the driverless car technology developer having backed a $3.2bn round last year.
Marqeta marks off $1.41bn initial public offering
The payment card technology provider, which counts Visa, CommerzBank, CreditEase and Mastercard as investors, has added about $190m to close its IPO.
Verve Therapeutics beats its way to $267m IPO
GV and Novo-backed cardiovascular disease drug developer Verve priced an upscaled initial public offering above its range.
Motif FoodWorks makes $226m series B move
Motif FoodWorks, launched by Gingko Bioworks, has pocketed $226m in a round backed by returning investor Louis Dreyfus a month after Gingko agreed to a reverse merger.
Umoja draws on SoftBank for $210m
SoftBank Vision Fund 2 co-led a series B round for immunotherapy developer Umoja Biopharma with Cormorant Asset Management.
Guideline gathers $200m
Propel Venture Partners has helped the retirement plan provider increase its overall funding to $344m by investing in a round led by General Atlantic.
Xiaoetong turns to series D for $120m
The Tencent and TAL Education-backed business management platform developer received the capital from IDG Capital, Hillhouse Capital, GGV Capital and Qiming Venture Partners.
Addepar absorbs $150m in series F funding
The CreditEase-backed wealth management software provider was valued at $2bn after securing investment from D1 Capital Partners.
Uberall undertakes $115m series C
The marketing platform developer is using cash from the United Internet-backed round to acquire MomentFeed, a deal that will allow Rockfish to exit.
G2 Venture Partners closes $500m Fund II
Shell Ventures has re-upped in G2 Venture Partners’ sophomore fund, which was also backed by Mitsui, Daimler and ABB Switzerland.
Apollo assembles investors for $145m round
The Johnson & Johnson, GSK and AstraZeneca-backed drug developer raised the cash in a Patient Square Capital-led round that took its total funding beyond $200m.
Heliogen heats up with $108m
The CSP technology developer revealed two new funding rounds including an $83m bridge round backed by ArcelorMittal and Edison International.